GPBP1L1 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 5.618400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
6.879200E-01
Normal-vs-Stage2
6.231800E-01
Normal-vs-Stage3
4.348300E-02
Normal-vs-Stage4
4.833600E-01
Stage1-vs-Stage2
9.774200E-01
Stage1-vs-Stage3
1.621960E-01
Stage1-vs-Stage4
3.079400E-01
Stage2-vs-Stage3
6.203800E-02
Stage2-vs-Stage4
1.376250E-01
Stage3-vs-Stage4
3.610000E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
5.314200E-01
Normal-vs-AfricanAmerican
7.468800E-01
Normal-vs-Asian
7.332800E-01
Caucasian-vs-AfricanAmerican
7.075000E-01
Caucasian-vs-Asian
7.837600E-01
AfricanAmerican-vs-Asian
9.137200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
5.024000E-01
Normal-vs-Female
6.377000E-01
Male-vs-Female
5.178600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
5.439800E-01
Normal-vs-Age(41-60Yrs)
9.352000E-01
Normal-vs-Age(61-80Yrs)
4.120000E-01
Normal-vs-Age(81-100Yrs)
4.440200E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
5.421000E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
9.050400E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
9.121400E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
9.757000E-03
Age(41-60Yrs)-vs-Age(81-100Yrs)
1.744790E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
9.888600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
3.833000E-01
Normal-vs-Daily Drinker
5.598000E-01
Normal-vs-Weekly Drinker
1.705610E-01
Normal-vs-Occasional Drinker
9.149200E-01
Normal-vs-Social Drinker
4.539000E-01
Non Drinker-vs-Daily Drinker
6.878400E-01
Non Drinker-vs-Weekly Drinker
4.785400E-01
Non Drinker-vs-Occasional Drinker
4.790000E-02
Non Drinker-vs-Social Drinker
4.619800E-01
Daily Drinker-vs-Weekly Drinker
3.411600E-01
Daily Drinker-vs-Occasional Drinker
1.691560E-01
Daily Drinker-vs-Social Drinker
7.603000E-01
Weekly Drinker-vs-Occasional Drinker
1.284030E-02
Weekly Drinker-vs-Social Drinker
1.384950E-01
Occasional Drinker-vs-Social Drinker
1.855020E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
1.172360E-01
Normal-vs-Grade 2
2.757200E-03
Normal-vs-Grade 3
4.220100E-03
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
1.318410E-03
Grade 1-vs-Grade 3
3.777000E-03
Grade 1-vs-Grade 4
1.172360E-01
Grade 2-vs-Grade 3
7.952000E-01
Grade 2-vs-Grade 4
2.757200E-03
Grade 3-vs-Grade 4
4.220100E-03
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
3.474000E-01
Normal-vs-NonDiabetic
5.011800E-01
Diabetic-vs-NonDiabetic
4.776800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
7.357800E-01
Normal-vs-NoPancreatitis
4.627800E-01
Pancreatitis-vs-NoPancreatitis
4.219800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
5.192200E-01
Normal-vs-N1
6.069800E-01
N0-vs-N1
5.658200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
7.355000E-01
Normal-vs-TP53-NonMutant
5.823200E-01
TP53-Mutant-vs-TP53-NonMutant
3.144100E-03
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
